CSIMarket
 


Htg Molecular Diagnostics Inc  (HTGM)
Other Ticker:  
 

Htg Molecular Diagnostics Inc's Working Capital Ratio

HTGM's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2023, Working Capital Ratio deteriorated to 1.4 below Htg Molecular Diagnostics Inc's average Working Capital Ratio.

Within Laboratory Analytical Instruments industry 29 other companies have achieved higher Working Capital Ratio than Htg Molecular Diagnostics Inc in first quarter 2023. While Working Capital Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 2355 to 3148.

Explain Working Capital Ratio
How much in Current Assets HTGM´s has?
What is the value of HTGM´s Current Liabilities?


HTGM Working Capital Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities Change -22.79 % -16.82 % -15.61 % 42.25 % 1.89 %
Y / Y Current Assets Change -63.85 % -42.43 % -66.07 % -46.24 % -27.69 %
Working Capital Ratio MRQ 1.4 1.89 1.58 1.9 2.99
HTGM's Total Ranking # 3148 # 2355 # 2905 # 2401 # 1638
Seq. Current Liabilities Change -20.7 % 21.26 % -32.86 % 19.6 % -14.57 %
Seq. Current Assets Change -41.3 % 45.3 % -44.26 % -23.97 % -6.51 %



Working Capital Ratio first quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 30
Healthcare Sector # 915
Overall Market # 3148


Working Capital Ratio Statistics
High Average Low
10.76 4.21 0.71
(Mar 31 2018)   (Mar 31 2015)




Financial Statements
Htg Molecular Diagnostics Inc's Current Liabilities $ 7 Millions Visit HTGM's Balance sheet
Htg Molecular Diagnostics Inc's Current Assets $ 9 Millions Visit HTGM's Balance sheet
Source of HTGM's Sales Visit HTGM's Sales by Geography


Cumulative Htg Molecular Diagnostics Inc's Working Capital Ratio

HTGM's Working Capital Ratio for the trailling 12 Months

HTGM Working Capital Ratio

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities TTM Growth -22.79 % -16.82 % -15.61 % 42.25 % 1.89 %
Y / Y Current Assets TTM Growth -63.85 % -42.43 % -66.07 % -46.24 % -27.69 %
Working Capital Ratio TTM 1.73 2.11 2.33 2.83 3.57
Total Ranking TTM # 4353 # 3646 # 4199 # 1540 # 1199
Seq. Current Liabilities TTM Growth -20.7 % 21.26 % -32.86 % 19.6 % -14.57 %
Seq. Current Assets TTM Growth -41.3 % 45.3 % -44.26 % -23.97 % -6.51 %


On the trailing twelve months basis In spite of the year on year decrease in HTGM's Current Liabilities to $6.56 millions, cumulative Working Capital Ratio to 1.73 below the HTGM average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 33 other companies have achieved higher Working Capital Ratio than Htg Molecular Diagnostics Inc. While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the forth quarter 2022 from 3646 to 4353.

Explain Working Capital Ratio
How much in Current Assets HTGM´s has?
What is the value of HTGM´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 34
Healthcare Sector # 1124
Within the Market # 4353


trailing twelve months Working Capital Ratio Statistics
High Average Low
7.71 3.85 1.2
(Dec 31 2018)   (Dec 31 2017)




Companies with similar Working Capital Ratio in the quarter ending Mar 31 2023, within Laboratory Analytical Instruments Industry Working Capital RatioMar 31 2023 MRQ Current AssetsMar 31 2023 MRQ Current Liabilities
Codex Dna Inc   3.82 $ 42.939  Millions$ 11.240  Millions
Bionano Genomics Inc   3.74 $ 142.557  Millions$ 38.135  Millions
Pacific Biosciences Of California Inc   3.69 $ 981.111  Millions$ 265.674  Millions
Phenomex Inc   2.77 $ 131.642  Millions$ 47.442  Millions
Akoya Biosciences Inc   2.76 $ 91.674  Millions$ 33.223  Millions
Perkinelmer Inc  2.43 $ 3,795.607  Millions$ 1,563.739  Millions
Agilent Technologies inc   2.37 $ 3,949.000  Millions$ 1,666.000  Millions
Harvard Bioscience Inc  2.26 $ 52.449  Millions$ 23.217  Millions
Kewaunee Scientific Corporation  2.20 $ 87.920  Millions$ 40.053  Millions
Bruker Corporation  2.03 $ 2,133.000  Millions$ 1,048.500  Millions
Avantor Inc   1.57 $ 2,627.300  Millions$ 1,669.500  Millions
Mettler toledo International Inc   1.43 $ 1,286.767  Millions$ 897.118  Millions
Illumina Inc   1.42 $ 3,172.000  Millions$ 2,230.000  Millions
Htg Molecular Diagnostics Inc  1.40 $ 9.187  Millions$ 6.559  Millions
Thermogenesis Holdings Inc   1.05 $ 10.969  Millions$ 10.471  Millions
Precipio inc   0.99 $ 3.995  Millions$ 4.017  Millions
Accelerate Diagnostics Inc   0.63 $ 42.834  Millions$ 68.125  Millions

Date modified: 2023-05-14T14:09:45+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com